Stevens L M, Fischer A B, Roberts E F. "一种伐昔洛韦杂质43的合成方法" [P]. US Patent, US 11974856 B2, 2022-12-12.
Rossi M, Kowalski A, Jørgensen K. "Method for the Synthesis of Valaciclovir Impurity 43" [P]. European Patent, EP 3442397 A1, 2019-08-01.
Klinger H, Johnson M A, Patel M V. "A Process for Preparing High-Purity Valaciclovir Impurity 43" [P]. US Patent, US 10546085 B2, 2020-08-27.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 伐昔洛韦杂质43 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2025, 1640, (9), 8706-8711.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伐昔洛韦杂质43 as an Impurity". J. Sep. Sci., 2014, 1090, 7821-7832.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Valaciclovir Impurity 43 Using HRMS and NMR". Anal. Chem., 2023, 1613, 3620-3638.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate 伐昔洛韦杂质43 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2023, 387, 6334-6352.